Volume 10; Issue 6

Main
Anti-Cancer Drugs
Volume 10; Issue 6

Anti-Cancer Drugs

Volume 10; Issue 6

1

Synthesis and cytotoxic activity of thiazolyl indolequinones

Moody, Christopher J, Roffey, Jonathan RA, Swann, Elizabeth, Lockyer, Stacey, Houlbrook, Susan, Stratford, Ian J

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 877 KB

1999

2

Effect of cyclosporin A on protein binding of teniposide in cancer patients

Toffoli, Giuseppe, Aita, Paola, Sorio, Roberto, Corona, Giuseppe, Bertola, Antonella, Colussi, Anna Maria, Robieux, Isabelle, Boiocchi, Mauro

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 567 KB

1999

3

Medical care consumption in a phase III trial comparing irinotecan with infusional 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer after 5-FU failure

Schmitt, C, Blijham, G, Jolain, B, Rougier, P, Cutsem, E Van

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 487 KB

1999

4

Phase II trial of 5-fluorouracil, folinic acid and recombinant α-2a-interferon in patients with advanced colorectal cancer

Ravandi, Farhad, Rytting, Michael E, Osmon, Carlos, Braud, Edward L, Roach, Ralph W, Edwards, Kimberly, Winn, Rodger, Abbruzzese, James L, Pazdur, Richard

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 438 KB

1999

5

Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine

Gross, Marine, Hiesse, Christian, Kriaa, Fayçal, Goldwasser, François

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 301 KB

1999

6

Time-schedule dependency of S 16020, a new topoisomerase II inhibitor

Soudon, J, Milano, G, Poullain, M G, Fischel, J L, Formento, P, Berlion, M, Giroux, B

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 488 KB

1999

7

Prolonged infusion of gemcitabine in stage IV breast cancer

Akrivakis, Konstantin, Schmid, Peter, Flath, Bernd, Schweigert, Markus, Sezer, Orhan, Mergenthaler, Hans-Günther, Possinger, Kurt

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 468 KB

1999

8

Vinflunine, a new vinca alkaloid

Jean-Decoster, Catherine, Brichese, Laetitia, Barret, Jean-Marc, Tollon, Yvette, Kruczynski, Anna, Hill, Bridget T, Wright, Michel

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 542 KB

1999

9

Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin

Dempke, Wolfram, Voigt, Wieland, Grothey, Axel, Schmoll, Hans-Joachim

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 356 KB

1999

10

Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase IIα and IIβ isoforms

van Hille, B, Perrin, D, Hill, B T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 750 KB

1999

11

Modulation of 5-fluorpuracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activities

Katona, Csilla, Tímár, Ferenc, Jeney, András, Fischel, Jean L, Milano, Gerard, Pandi, Erzsébet, Kralovánszky, Judit

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 558 KB

1999

12

Apoptosis induction and cell cycle perturbation in human hepatoma Hep G2 cells by 10-hydroxycamptothecin

Zhang, Xiong-Wen, and Bin Xu, Chen Qing

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 462 KB

1999

13

Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines

Hadfield, John A, Pavlidis, Vasilios H, Perry, Philip J, McGown, Alan T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 266 KB

1999

14

The cost—effectiveness of paclitaxel (Taxol)+ cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer

Annemans, Lieven, Giaccone, Giuseppe, Vergnenègre, Alain

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 731 KB

1999